anticancer protein (Adamed)

N/A

Report date: 2025/06/11 10:56:52

Base Information

Drug Nameanticancer protein (Adamed)

Drug Alias Nameapoptosis inducer (Adamed)ONCO-3CLA project (Adamed)AD-051.43-CLA

ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein

Mechanisms of ActionTumor necrosis factor receptor superfamily member 10A agonistsTumor necrosis factor receptor superfamily member 10B agonistsAngiogenesis inhibitors +[6]

TargetsTumor necrosis factor receptor superfamily member 10BVascular endothelial growth factor receptorTumor necrosis factor receptor superfamily member 10A

Therapy Area/IndicationsHematologic NeoplasmsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited StatesPoland

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesAdamed

China Registration ClassN/A

Develop Information

Active CompaniesAdamed

Inactive CompaniesN/A

Active IndicationsHematologic NeoplasmsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A